// November 28, 2023
FDA's Draft Guidance for Topical Ophthalmic Drug Products: USP Standards
This year has seen a flurry of activity by the U.S.
// June 08, 2023
Insights from India: Q&A with USP nitrosamines expert
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
// November 11, 2022
Latest nitrosamines recall spotlighting need to control pharmaceutical impurities
Revised on: January 17, 2023
// June 22, 2022
Avoid product recalls - Know your impurities
Impurities found in pharmaceuticals are a cause for concern.
